| Go Pro | AZ1 Chatter | IMYO FYI | Tell your friends and family about NICHEY & AZ1 |

The global biobanking market is primarily driven by the surging product adoption in understanding the pathogenic mechanisms, collecting high-quality and well-annotated human biospecimens, and identifying potential treatment targets for coronavirus disease (COVID-19).